Melatonin Should be Urgently Considered as a Cheap and Efficient COVID-19 Therapeutic
Journal Title: Women's Health Science Journal - Year 2021, Vol 5, Issue 2
Abstract
In a recent article [1] the authors highlight the urgent needs to develop efficient COVID-19 therapeutics to be rapidly applied in low-middle-income countries to forestall the collapse of overburdened health systems in resource limited settings. Among other agents, the paper mentions anti-inflammatory and immunomodulatory agents, but only as part of later-stage interventions aimed at preventing downstream consequences [1].
Authors and Affiliations
Tesarik J*
Keywords
Related Articles
- EP ID EP746506
- DOI 10.23880/whsj-16000160
- Views 1
- Downloads 0
The Impact of Sex Education among Brazilian Adolescents
By entering into the reality of public schools in Juiz de Fora (MG), the present study aims to describe the scenario of adolescent’s sexual experience altogether with its risks and consequences, considering previous rese...
Adhesiolysis in Women with Chronic Pelvic Pain and a Temporal Resolution of Pain
Study Objectives: To evaluate the duration of pain improvement after laparoscopic and/or robotic assisted adhesiolysis in women with prior abdominal or pelvic surgeries that have been diagnosed with chronic pelvic pain w...
Quality of Partogram Recordings and Perinatal Outcome at Muhimbili National Hospital Tanzania
Background: The management of labor using partograph is the standard way of improving both maternal and perinatal outcomes. The partogram increases the quality and regularity of all observations on the fetus and the moth...
Pregnancy Complicated by Q fever
Q fever r is a zoonosis caused by Coxiella burnetii which is highly contagious. Little is known about acquisition of Q fever during pregnancy, yet, it is known to be associated with severe maternal and fetal morbidity a...
Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge
Background: Monoclonal antibody (mAb) therapy has been recommended in non-hospitalized COVID-19 positive pregnant individuals with mild to moderate symptoms despite data on safety and efficacy. Objective: To assess short...